Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
8.04
+0.13 (1.64%)
At close: Aug 6, 2025, 4:00 PM
8.26
+0.22 (2.74%)
After-hours: Aug 6, 2025, 5:38 PM EDT
Regulus Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Regulus Therapeutics stock has a target of 70, which predicts a 770.65% increase from the current stock price of 8.04.
Price Target: $70.00 (+770.65%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 31, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Regulus Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +770.65% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $70 | Strong Buy | Maintains | $75 → $70 | +770.65% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +832.84% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +832.84% | Oct 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +832.84% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
1.91M
from 3.95M
Decreased by -51.66%
Revenue Next Year
2.89M
from 1.91M
Increased by 51.55%
EPS This Year
-9.89
from -20.94
EPS Next Year
-9.07
from -9.89
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.2M | 4.7M | 5.1M | ||
| Avg | 1.9M | 2.9M | 2.5M | ||
| Low | 303,800 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.5% | 147.8% | 78.0% | ||
| Avg | -51.7% | 51.5% | -13.5% | ||
| Low | -92.3% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.11 | -6.07 | -4.60 | ||
| Avg | -9.89 | -9.07 | -9.22 | ||
| Low | -10.53 | -10.76 | -13.42 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.